Skip to content

Thrombus Aspiration in Myocardial Infarction

Thrombus Aspiration in ST- Elevation Myocardial Infarction in Scandinavia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01093404
Acronym
TASTE
Enrollment
7243
Registered
2010-03-25
Start date
2010-07-31
Completion date
2013-08-31
Last updated
2016-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Keywords

Heart disease, Myocardial infarction, Angioplasty, Thrombus aspiration

Brief summary

Treatment of myocardial infarction (blood clot in the arteries of the heart) has improved after introduction of 24/7 balloon angioplasty to open the blocked artery. However, the clot itself is not routinely removed but recent data in smaller trials indicate that this might improve recovery and prognosis. In this multicenter study of 5000 patients referred to Scandinavian hospitals for myocardial infarction the investigators test the hypothesis that patients randomized to treatment with thrombus aspiration (removing the blood clot by manual suction) before conventional angioplasty will have a reduced risk of death, fewer rehospitalisations, fewer new myocardial infarctions, reduced risk of heart failure, better coronary artery flow after angioplasty and greater reduction of infarct size compared to patients randomized to conventional angioplasty alone.

Interventions

Aspiration of thrombus material before angioplasty

Sponsors

Uppsala University
CollaboratorOTHER
Region Örebro County
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with a diagnosis of ST-segment elevation myocardial infarction * Correspondence between ECG findings and culprit artery pathoanatomy * A minimum of 50% stenosis in culprit artery by visual estimate * Possibility to perform thrombus aspiration

Exclusion criteria

* Need for emergency coronary artery bypass grafting * Inability to provide informed consent * Age below 18 years * Previous randomization in the TASTE trial

Design outcomes

Primary

MeasureTime frameDescription
All-cause death30 daysDeath from any cause will be registered via national registries during the first 30 days after study inclusion.

Secondary

MeasureTime frameDescription
TIMI-flow grade3 hoursTIMI-flow, or Thrombolysis in Myocardial Infarction grading of flow is a semiquantitative method to assess coronary artery flow following balloon angioplasty.
All-cause death1 year to 10 years
Length of hospital stay1 month
Time to all-cause death or new myocardial infarction (first occurring) or in hospital treatment for heart failure30 days to 10 years
Time to acute coronary occlusion, stent thrombosis and restenosis in treated lesions1 year
Time to re-hospitalization with nonfatal reinfarction, heart failure and target vessel revascularization30 days to 10 years

Countries

Denmark, Iceland, Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026